Merina Ahmed

UK Consensus on Normal Tissue Dose Constraints for Stereotactic Radiotherapy

Gerard G. Hanna, Louise Murray, R. Patel et al. · Clinical Oncology · 2017 · 274 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Analysis of the efficacy and toxicity of sorafenib in thyroid cancer: a phase II study in a UK based population

Merina Ahmed, Yolanda Barbáchano, Angela M. Riddell et al. · European Journal of Endocrinology · 2011 · 198 citations

Medicine, Oncology, Pharmacotherapy +9

Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial

Amelia Clive, Hazel Taylor, Lee Dobson et al. · The Lancet Oncology · 2016 · 165 citations · Full text

Medicine, Oncology, Surgery +16

Two-Stage Phase I Dose-Escalation Study of Intratumoral Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers

Kevin J. Harrington, Eleni Karapanagiotou, Victoria Roulstone et al. · Clinical Cancer Research · 2010 · 121 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Dose-limiting Urinary Toxicity With Pembrolizumab Combined With Weekly Hypofractionated Radiation Therapy in Bladder Cancer

Alison Tree, Kelly Jones, S. Hafeez et al. · International Journal of Radiation Oncology*Biology*Physics · 2018 · 100 citations · Full text

Medicine, Oncology, Radiation Oncology +17